PTH and chronic kidney disease: Calcitriol or its analog paricalcitol, the more biologically active form of Vitamin D, decreases PTH and bone alkaline phosphatase but yields no change in bone mineralization when administered in G3-5 CKD or dialyzed patients [176,177].